Pseudomyxoma Peritonei and Ovarian Mucinous Borderline Tumor
Journal Title: Interventions in Gynaecology and Women’s Healthcare - Year 2018, Vol 2, Issue 4
Abstract
Pseudomyxoma peritonei is only rarely seen in conjunction with primary ovarian tumors. We describe a case of a late recurrence of a mucinous intestinal-type borderline ovarian tumor with disseminated peritoneal adenomucinosis. Pseudomyxoma peritonei (PMP) is a rare entity with an incidence of 2 per million individuals per year [1]. It is slowly progressive mucinous malignant disease confined to the peritoneal cavity, usually originating from the appendix [2]. The predisposed areas within the peritoneal cavity of PMP are defined by fluid absorption through lymphatic lacunae and lymphoid aggregates (greater omentum, right hemidiaphragm) and gravity (pelvic cavity, paracolic gutters) [3] The natural course of the disease is slow progression of peritoneal mucinous masses until death caused by complications due to the bulk of tumor. A 36-year old woman without comorbidities who underwent unilateral adnexectomy and appendectomy in 2011 with diagnosis of low grade ovarian intestinal type borderline mucinous tumor. CA19.9 tumor marker testing was slightly elevated, 78 U/ml; the others tumor markers were normal. Surgical exploration by median laparotomy showed widespread gelatinous mucinous ascites and a huge ruptured right ovarian tumor of 30 cm in diameter. All visible mucinous deposits were resected. The Immunohistochemistry study was: Ck7: +, Ck20: +++, CDX2: +, R.E: (-), R.P: (-), CEA: +, Muc2: +, Ki-67: + 5%. No adjuvant therapy was given. In 2013 she had a pregnancy by in vitro fertilization with cesarean delivery and no evidence of tumor recurrence at that time. In 2017 the patient wanted a new pregnancy. Due to the diagnosis of early ovarian failure, she was remitted to the Reproduction Unit again. During the ovarian stimulation, a large column of fluid was observed through sonographic exploration in the douglas space. The Ca19.9 tumor marker testing was elevated again, 80 U/ml. In the CT- scan there were signs of peritoneal carcinomatosis, so a diagnostic laparoscopy was performed showing a gelatinous-mucinous ascites and disseminated peritoneal carcinomatosis with implants widespread on the peritoneum, small intestine, colon, diaphragm and liver (Figures 1 & 2). A complete surgical debulking was judged to be technically impossible. Anatomopathological examination showed multiple deposits of mucus without visible tumor epithelial cells and some mucinous cells intestinal type in biopsied peritoneal implants with very mild atypia. Postoperatively no major wound complication occurred and 4 weeks after surgery, the woman was sent to Oncology to assess starting chemotherapy treatment.
Authors and Affiliations
Baquedano L, Lanzón A, Bolea R, José Y, Ruiz-Conde MA
Immunotherapy in Ovarian Cancer
Ovarian cancer ranks fifth with a 5-year survival of 40% for patients with advanced disease and remains the most lethal gynecologic malignancy among women [1]. Most patients with advanced disease undergo aggressive front...
Major Issues Related to Women Health, Social, Cultural and Economic Development
Present article sketches out major issues related to health, social, cultural, and economic wellbeing of the women. Most prevailing problems are related to malnutrition, sociality, sanitation, shelter, education, and liv...
The Psychological Impact of Foetal Loss at Term on Sudanese Mothers
This is a descriptive, cross-sectional study to explore and describe the psychological impact and social support following perinatal loss among Sudanese Mothers who have been through it before, hence, to evaluate it amon...
Clinical Biomarkers and Biotechnology in Fertile Window
The recognition of fertility is increasingly important in prestigious scientific groups and in renowned international schools [1]. In this sense, we have tried to objectify the changes observed in the evolutionary proces...
Changes in Skeletal System during Pregnancy
Pain localized at the pelvic girdle during and after pregnancy has been keyed out and registered as an entity since the 4th century BC by Hippocrates. Contemporary medical research since the early 20th century has attemp...